The United States leads with the highest nervous system disease mortality rate, significantly higher than Japan and the United Kingdom. Japan and the UK show notable year-on-year increases, while Spain and South Africa experienced slight declines. Colombia, Poland, and Slovenia show the most significant growth among listed countries. Most European countries generally reported lower mortality, with Luxembourg having the least. Over the last five years, mortality varies with countries like Slovenia and Estonia showing high growth rates, whereas Spain and South Africa see reductions in mortality cases.
Future Trends to Watch:
- Technological advancements and medical innovations may reduce mortality rates significantly.
- Improved healthcare access in developing countries might alter the current trends.
- Consider watching data on early diagnosis and intervention effectiveness which could impact future mortality trends.
- Aging populations in countries like Japan and the US could continue affecting mortality statistics.
Top countries in Nervous System Disease Mortality by Country
| # | 10 Countries | Units (Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 307,960 | 2023 | +5.13% | +6.47% | View data |
| 2 | 2 Japan | 59,690 | 2023 | +4.86% | +4.34% | View data |
| 3 | 3 United Kingdom | 54,000 | 2023 | +5.26% | +5.78% | View data |
| 4 | 4 Brazil | 53,140 | 2023 | +4.33% | +5.21% | View data |
| 5 | 5 Spain | 25,370 | 2023 | -1.54% | -0.7% | View data |
| 6 | 6 Canada | 15,850 | 2023 | +1.55% | +1.43% | View data |
| 7 | 7 South Korea | 15,680 | 2023 | +4.17% | +4.09% | View data |
| 8 | 8 Mexico | 13,600 | 2023 | +1.83% | +1.87% | View data |
| 9 | 9 Australia | 11,670 | 2023 | +3.73% | +4.66% | View data |
| 10 | 10 Finland | 11,640 | 2023 | +3.27% | +3.37% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...